The PI3K/AKT/mTOR signaling pathway is a promising target with respect to its frequent dysregulation in hepatocellular carcinoma and its central role in regulating cell proliferation, migration, survival and angiogenesis[4,5]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.